Hsu, Wei-Fan http://orcid.org/0000-0002-0738-417X
Chen, Chi-Yi
Tseng, Kuo-Chih
Lai, Hsueh-Chou
Kuo, Hsing-Tao
Hung, Chao-Hung
Tung, Shui-Yi
Wang, Jing-Houng
Chen, Jyh-Jou
Lee, Pei-Lun
Chien, Rong-Nan
Lin, Chun-Yen http://orcid.org/0000-0003-3007-3190
Yang, Chi-Chieh
Lo, Gin-Ho
Tai, Chi-Ming
Lin, Chih-Wen
Kao, Jia-Horng http://orcid.org/0000-0002-2442-7952
Liu, Chun-Jen http://orcid.org/0000-0001-8082-7144
Liu, Chen-Hua http://orcid.org/0000-0003-3622-9707
Yan, Sheng-Lei
Bair, Ming-Jong
Su, Wei-Wen
Chu, Cheng-Hsin
Chen, Chih-Jen
Lo, Ching-Chu
Cheng, Pin-Nan http://orcid.org/0000-0001-9331-9018
Chiu, Yen-Cheng
Wang, Chia-Chi
Cheng, Jin-Shiung
Tsai, Wei-Lun
Lin, Han-Chieh
Huang, Yi-Hsiang http://orcid.org/0000-0001-5241-5425
Tsai, Pei-Chien
Huang, Jee-Fu
Dai, Chia-Yen
Chuang, Wan-Long
Yu, Ming-Lung http://orcid.org/0000-0001-8145-1900
Peng, Cheng-Yuan http://orcid.org/0000-0001-9030-6086
Funding for this research was provided by:
China Medical University Hospital (DMR-108-018)
Kaohsiung Medical University (KMU-TC108B07)
Ministry of Health and Welfare (MOHW106-TDU-B-212-113004)
Article History
Received: 12 November 2019
Accepted: 5 March 2020
First Online: 25 March 2020
Competing interests
: C.Y. Peng has served as an advisory committee member for AbbVie, Bristol-Myers Squibb, Gilead, and Merck Sharp & Dohme. All other coauthors have no conflicts of interest to declare.